Advance Biomedical Devices: Assessing Readiness to Export
Product Suitability
Advance Biomedical Devices, Inc. (ABD) products are in a state of readiness to begin exporting to Europe because the Continent provides countries with similar market characterisitics and requirements to its home market, the United States.
The products are also ready for exporting to emerging markets such as Brazil, Russia, India, and China (BRIC) among others due to the rapidly progressive living standards and an expanding middle class with rising economic potentials in these countries.
ABD’s Speedheal branded products have strong possibilities of advantageous demand in all types of foreign countries due to the following reasons:
- It’s Speedheal products produce exceptional sales performance in the domestic market of the United States.
- The products address universal health needs through the promotion of healing and the reduction of postsurgical pain by keeping the wound area from swelling.
- The products are unique and cater to current and evolving health needs not well served internationally.
- The devices are relatively small and portable and thus miniaturization remains one of ABD’s competitive advantages.
- The product prices are relatively affordable and inexpensive to ship based on the miniature sizes.
- ABD’s products were seldom defective and replacement of defective ones was a solution instituted by the company that augured well for good international business practice in after-sales service.
- Speedheal devices are sensitive to changes in temperature and humidity and management has identified that suitable storages are available internationally.
Management Competencies and Readiness for Internationalization
ABD has a skilful management team whose members have worked extensively in the European market, the Pacific RIM and Latin America. The international